8-K: TruGolf Secures $5 Million in Funding, Completes Note Exchange, and Extends Warrants
Capital Structure Update
TruGolf Holdings, Inc. announced the completion of a $3.9 million convertible note exchange, a $5.0 million cash exercise of preferred warrants, and a two-year extension of remaining preferred warrants.
Summary
- TruGolf Holdings, Inc. completed the exchange of $3,938,311 in remaining PIPE Convertible Notes into 3,938.311 shares of Series A Preferred Stock.
- A holder exercised Preferred Warrants for 5,555 shares of Series A Preferred Stock, generating approximately $5.0 million in cash proceeds for the company.
- The company extended the expiration date of the Preferred Warrants held by investors by two years.
- A Waiver Agreement was executed on July 21, 2025, eliminating the company's right to object to an Exercise Notice for a portion of the Preferred Warrant, unless the company completes an equity financing raising over $10,000,000 prior to the three-month anniversary of the Note Exchange.
- The company reimbursed Kelley Drye & Warren, LLP, counsel to the lead Holder, $20,000 for legal costs and expenses related to the Waiver Agreement.
Sentiment
Score: 7
Explanation: The filing indicates positive steps in strengthening the company's balance sheet by converting debt to equity and securing immediate cash through warrant exercise. The extension of warrants also provides future flexibility. The conditional waiver related to a larger financing is a minor point but doesn't detract significantly from the overall positive financial actions.
Positives
- Secured approximately $5.0 million in cash proceeds from the exercise of Preferred Warrants, providing immediate capital.
- Successfully completed the exchange of all remaining $3,938,311 PIPE Convertible Notes into Series A Preferred Stock, simplifying the capital structure and reducing debt.
- Extended the expiration date of Preferred Warrants by two years, potentially allowing more time for future exercises and capital infusion.
- The Waiver Agreement facilitates future warrant exercises by removing the company's right to object, subject to a condition related to a larger financing.
Negatives
- The waiver of the company's right to object to warrant exercise is conditional on not completing a Qualified Financing of over $10 million, suggesting a potential challenge in securing larger equity funding.
- The company is responsible for certain fees, including $20,000 in legal fees for the lead Holder's counsel, and potential placement agent, financial advisory, and transfer agent fees.
Risks
- Failure to complete a Qualified Financing of more than $10,000,000 prior to the three-month anniversary of the Note Exchange could impact the company's ability to control future warrant exercises.
- Reliance on exemptions from registration (Sections 4(a)(2) and 3(a)(9) of the Securities Act and Regulation D) for the equity securities transactions carries inherent regulatory compliance risks.
Future Outlook
The filing indicates that the company may seek to complete an equity financing of more than $10,000,000, which would impact the terms of the Preferred Warrant exercise waiver. The extension of Preferred Warrants by two years suggests a longer-term view on potential future capital infusions from these instruments.
Management Comments
- The Company desires to irrevocably waive the Company's right to object to an Exercise Notice and for the Company to have been deemed to have consented to such Exercise Notice, and the Company hereby agrees and acknowledges that, from and after the Preferred Warrant Exercise Waiver Time, it shall accept the delivery of any Exercise Notices under the Preferred Warrant and deliver to the Holder (or its designee) such aggregate number of shares of Series A Convertible Preferred Stock of the Company as required to be delivered in connection therewith.
Industry Context
NA
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Warrant Exercise Consent Waiver | The Company irrevocably waived its right to object to an Exercise Notice for the Preferred Warrant, and is deemed to have consented, unless a Qualified Financing of over $10 million occurs prior to the Preferred Warrant Exercise Waiver Time. | 2025-07-21 | Streamlines the process for holders to exercise Preferred Warrants, potentially facilitating future capital inflows, but introduces a condition tied to larger equity financing efforts. |
| Most Favored Nations Clause | The Company agreed that terms offered to other holders in future 'Settlement Documents' will not be more favorable than those offered to the Holder in this Waiver. If more favorable terms are offered, this Agreement will be automatically amended to reflect those terms. | 2025-07-21 | Ensures equitable treatment for the Holder relative to other investors in future financing arrangements, potentially increasing investor confidence and reducing dilution concerns for this specific holder. |
Stakeholder Impact
- Shareholders: The conversion of convertible notes to Series A Preferred Stock reduces debt, which can be positive. The exercise of warrants for cash provides capital, but also increases the number of preferred shares outstanding, potentially leading to future dilution if converted to common stock. The extension of warrants defers potential future dilution but keeps the option open.
- Creditors: The exchange of convertible notes for equity reduces the company's debt obligations, which is generally positive for creditors.
Next Steps
- The company may pursue a 'Qualified Financing' of over $10,000,000 in equity proceeds, which would affect the terms of the Preferred Warrant exercise waiver.
- The Preferred Warrant Exercise Waiver Time, the three-month anniversary of the Closing Date (in the Exchange Agreement), is a future milestone that will determine the finality of the waiver.
Key Dates
| Date | Description |
|---|---|
| 2024-02-02 | Date of the original Securities Purchase Agreement between the Company and Holders. |
| 2025-04-22 | Date of the Waiver and Exchange Agreement, where Original Warrants were exchanged for Series A Preferred Stock and Preferred Warrants. |
| 2025-07-21 | Date of the Waiver Agreement, the waiver of remaining closing condition for Note Exchange, consummation of Note Exchange, extension of Preferred Warrants, and exercise of Preferred Warrants for cash proceeds. |
| 2025-07-22 | Date of signing the Current Report on Form 8-K. |
| 2025-10-21 | Approximate three-month anniversary of the Note Exchange (Preferred Warrant Exercise Waiver Time), after which the company's waiver of objection to warrant exercise becomes unconditional if a Qualified Financing has not occurred. |
Recommendation
holdThe filing details positive steps in capital management, including debt-to-equity conversion and a cash infusion from warrant exercise, which are generally favorable. However, the company's ongoing reliance on complex financing instruments and the conditional nature of the warrant exercise waiver suggest that while immediate financial health is addressed, long-term stability and growth trajectory remain to be fully demonstrated. The 'Most Favored Nations' clause is a good sign for this specific investor, but the overall picture warrants a 'hold' as the company navigates its capital structure and seeks larger equity financing.
Keywords
TruGolf Holdings, Deep Medicine Acquisition Corp, SEC filing, 8-K, convertible notes, Series A Preferred Stock, warrants, equity financing, capital raise, PIPE Convertible Notes, Preferred Warrants, corporate finance, capital structure, investment, TRUG
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.